
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology, Medical School, University of Zaragoza, 50009 Zaragoza, Spain
To choose a sensitive protocol to discriminate populations exposed and not exposed to inducers, five urinary metabolite ratios (MRs) [MR1 (17X + 17U)/137X, MR2 (5-acetylamino-6-formylamino-3-methyluracil [AFMU] + 1X + 1U)/17U, MR3 (17X/137X), MR4 (AFMU + 1X + 1U + 17X + 17U)/137X, and MR5 (AFMU + 1X + 1U)/17X] were calculated in 45 h and 024 h urine samples after caffeine intake. One hundred twenty-five healthy volunteers (59 nonsmokers and 66 smokers) were included in the study. All ratios showed a log-normal distribution. MR2 in the two time intervals was the only ratio nondependent on the urine flow. Differences between nonsmokers and smokers could be detected with all ratios at 45 h. However, only MR2 and, to a lesser extent, MR5 allowed the discrimination of higher cytochrome P450 1A2 (CYP1A2) activity in smokers in the 024 h sample. Although smokers had increased urinary mutagenicity in relation to nonsmokers, a significant association between MRs and urine mutagenicity was observed only with MR2 in the 45 h interval; this ratio/time schedule being that of higher association with tobacco consumption. The most flow-dependent ratios, MR1, MR3, and MR4, were closely correlated with each other at the two intervals. The flow dependency profile of each ratio may explain their different power to indicate both tobacco exposure and tobacco-derived mutagenicity. In conclusion, MR2 in the period of 45 h after caffeine intake seems preferable, especially at high urine flow rates.
This article has been cited by other articles:
![]() |
B Sinues, A Fanlo, E Mayayo, C Carcas, J Vicente, I Arenaz, and A Cebollada CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives Human and Experimental Toxicology, May 1, 2008; 27(5): 367 - 372. [Abstract] [PDF] |
||||
![]() |
M. J. Kennedy, S. M. Abdel-Rahman, A. D. M. Kashuba, and J. S. Leeder Comparison of Various Urine Collection Intervals for Caffeine and Dextromethorphan Phenotyping in Children J. Clin. Pharmacol., July 1, 2004; 44(7): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pavanello, P. Simioli, S. Lupi, P. Gregorio, and E. Clonfero Exposure Levels and Cytochrome P450 1A2 Activity, but not N-Acetyltransferase, Glutathione S-Transferase (GST) M1 and T1, Influence Urinary Mutagen Excretion in Smokers Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 998 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vermeulen, H. Wegh, R. P. Bos, and H. Kromhout Weekly Patterns in Smoking Habits and Influence on Urinary Cotinine and Mutagenicity Levels: Confounding Effect of Nonsmoking Policies in the Workplace Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1205 - 1209. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |